Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of sodium dichloroisocyanurate (NaDCC) and a pharmaceutical formulation prepared therefrom

Use of sodium dichloroisocyanurate (NaDCC) and a pharmaceutical formulation prepared therefrom

US Patent 11944632 · Granted Apr 2, 2024

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Phage derived antimicrobial activities2019
Chimeric antibacterial polypeptides2018
Modified SAK gene for the production of recombinant proteins2017
Phage derived antimicrobial activities2017
Chimeric antibacterial polypeptides2017
Incapacitated whole-cell immunogenic bacterial compositions produced by recombin2016
Modified SAK gene for the production of recombinant proteins2014
Phage derived antimicrobial activities2014
Phage derived antimicrobial activities2012
Lysin-deficient bacteriophages having reduced immunogenicity2006
Incapacitated whole-cell immunogenic bacterial compositions2005
Lysin-deficient bacteriophages having reduced immunogenicity2005